Latest Financial Management News

Trinex Minerals has completed a significant capital raise and board restructure during the June 2025 quarter, positioning itself for renewed focus on lithium exploration in Australia and Canada.

Wingara AG has finalised the sale of its JC Tanloden machinery and reported a cash balance of $531,000 as of June 30, 2025, while the anticipated Terra Firma transaction remains unresolved.

Axiom Properties Limited reported a $1.67 million increase in cash reserves this quarter, driven by strong performance from its PaySure business and completion of the Mt Barker Glenlea Estate project.

Bindi Metals reports steady progress on its Lisa antimony-gold project in Serbia alongside promising gallium mineralisation at its Australian Biloela copper-gold project, maintaining a solid cash position.

Discovery Alaska Limited has terminated its Vinasale Gold Project lease to conserve funds, while maintaining full ownership of the Chulitna Gold Project and exploring new opportunities to boost its portfolio.

Lion Energy Limited reported a net cash outflow in Q2 2025 but maintains a solid cash position of AUD 2.13 million alongside a convertible note facility, signaling cautious optimism for its exploration activities.

Rey Resources reports continued exploration progress in Western Australia's Canning Basin alongside a stable financial footing supported by substantial shareholder loans.

Minbos Resources has secured key financing and made significant construction strides on its Angolan phosphate fertilizer plant, while rolling out promising new fertilizer blends to support local agriculture.

ActivEX Limited reports a maiden gold resource of 310,000 ounces at its Gilberton project and broadens its rare earth element exploration with new tenement applications in Queensland.

Liontown Resources reported robust FY25 results with over 294,000 dmt of spodumene concentrate produced and commenced underground mining on schedule. The company is transitioning to 100% underground production by Q3 FY26, aiming for scalable, low-cost operations from FY27 despite a 36% drop in spodumene prices.

Careteq Limited reports a significant reduction in operating cash outflow and modest revenue growth for FY25, while facing delays in its key platform integration and a dispute with the ATO over R&D claims.

SomnoMed reports a robust Q4 FY25 with 25% revenue growth and a milestone of treating over 1 million patients, while gearing up for significant capacity expansion and clinical advancements.